Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Elm

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
JAMA Neurology|April 30, 2019
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical TrialHolly Tillman, S Claiborne Johnston, Mary Farrant, et al.
Clinical and Translational Science|March 20, 2021
A pharmacokinetic simulation study to assess the performance of a sparse blood sampling approach to quantify early drug exposureAbhishek G Sathe, Richard C Brundage, Vijay Ivaturi, et al.
Neurology|August 14, 2023
Desirability of Outcome Ranking for Status Epilepticus: A Benefit-Risk Approach to Design and Analyses of Clinical SE TrialsJames M Chamberlain, Jaideep Kapur, Robert S Silbergleit, et al.
BMC Medical Informatics and Decision Making|December 22, 2018
Characterizing patient compliance over six months in remote digital trials of Parkinson's and Huntington diseaseShani Cohen, Zeev Waks, Jordan J Elm, et al.
The New England Journal of Medicine|May 17, 2018
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIAS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Epilepsia|April 24, 2010
How common is brain atrophy in patients with medial temporal lobe epilepsy?Leonardo Bonilha, Jordan J Elm, Jonathan C Edwards, et al.
Clinical Trials (London, England)|June 14, 2014
Screen failure data in clinical trials: Are screening logs worth it?Jordan J Elm, Yuko Palesch, J Donald Easton, et al.
Clinical Trials (London, England)|April 13, 2012
A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacyBarbara C Tilley, Arch G Mainous, Jordan J Elm, et al.
Stroke|May 24, 2018
Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory AnalysisKevin N Sheth, Nils H Petersen, Ken Cheung, et al.
Stroke|December 19, 2022
Recruitment in Acute Stroke Trials: Challenges and Potential SolutionsJoseph P Broderick, Yasmin N Aziz, Opeolu M Adeoye, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
JAMA Neurology|April 30, 2019
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical TrialHolly Tillman, S Claiborne Johnston, Mary Farrant, et al.
Clinical and Translational Science|March 20, 2021
A pharmacokinetic simulation study to assess the performance of a sparse blood sampling approach to quantify early drug exposureAbhishek G Sathe, Richard C Brundage, Vijay Ivaturi, et al.
Neurology|August 14, 2023
Desirability of Outcome Ranking for Status Epilepticus: A Benefit-Risk Approach to Design and Analyses of Clinical SE TrialsJames M Chamberlain, Jaideep Kapur, Robert S Silbergleit, et al.
BMC Medical Informatics and Decision Making|December 22, 2018
Characterizing patient compliance over six months in remote digital trials of Parkinson's and Huntington diseaseShani Cohen, Zeev Waks, Jordan J Elm, et al.
The New England Journal of Medicine|May 17, 2018
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIAS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Epilepsia|April 24, 2010
How common is brain atrophy in patients with medial temporal lobe epilepsy?Leonardo Bonilha, Jordan J Elm, Jonathan C Edwards, et al.
Clinical Trials (London, England)|June 14, 2014
Screen failure data in clinical trials: Are screening logs worth it?Jordan J Elm, Yuko Palesch, J Donald Easton, et al.
Clinical Trials (London, England)|April 13, 2012
A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacyBarbara C Tilley, Arch G Mainous, Jordan J Elm, et al.
Stroke|May 24, 2018
Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory AnalysisKevin N Sheth, Nils H Petersen, Ken Cheung, et al.
Stroke|December 19, 2022
Recruitment in Acute Stroke Trials: Challenges and Potential SolutionsJoseph P Broderick, Yasmin N Aziz, Opeolu M Adeoye, et al.
Pageof 6